A new automated cell washer device for thawed cord blood units

Transfusion

Volumn 44, Issue 6, 2004, Pages 900-906

  Perotti, Cesare G ^a   Del Fante, Claudia ^b   Viarengo, Gianluca ^b   Papa, Pietro ^b   Rocchi, Loretta ^b   Bergamaschi, Paola ^b   Bellotti, Laura ^b   Marchesi, Andrea ^b   Salvaneschi, Laura ^b  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD34 ANTIGEN; CD8 ANTIGEN; DIMETHYL SULFOXIDE;

ARTICLE; AUTOMATION; BACTERIUM CULTURE; CELL COUNT; CELL LOSS; CELL VIABILITY; CENTRIFUGATION; CLONOGENIC ASSAY; CRYOPRESERVATION; CYTOFLUOROMETRY; DEVICE; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; THAWING; UMBILICAL CORD BLOOD;

AUTOMATION; BLOOD CELL COUNT; BLOOD CELLS; BLOOD PRESERVATION; CELL SEPARATION; CENTRIFUGATION; CHROMATOGRAPHY, GAS; COLONY-FORMING UNITS ASSAY; CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; DIMETHYL SULFOXIDE; FETAL BLOOD; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; INFANT, NEWBORN; SOFTWARE;

EID: 2942594147     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2004.03389.x     Document Type: Article

References (31)

1. Broxmeyer HE. Questions to be answered regarding umbilical cord blood hematopoietic stem and progenitor cells and their use in transplantation. Transfusion 1995;35:394.
2. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med 1997;337:373-81.
3. Madrigal JA, Cohen SB, Gluckman E, et al. Does cord blood transplantation result in lower graft-versus-host disease? It takes more than two to tango. Hum Immunol 1997;56:1-5.
4. Gluckman E. Hematopoietic stem cell transplants using umbilical cord blood. N Engl J Med 2001;344:1860-1.
5. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental blood transplants from unrelated donors. N Engl J Med 1998;339:1565-77.
6. Migliaccio AR, Adamson JW, Stevens CE, et al. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000;96:2717-22.
7. Regidor C, Posada M, Monteagudo D, et al. Umbilical cord blood banking for unrelated transplantation: evaluation of cell separation and storage methods. Exp Hematol 1999;27:380-5.
8. Almici C, Carlo-Stella C, Mangoni L, et al. Density separation of umbilical cord blood and recovery of hemopoietic progenitor cells: implications for cord blood banking. Stem Cells 1995;13:533-40.
9. Rubinstein P, Dobrila L, Rosenfield RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A 1995;92:10119-22.
10. Carpenter JF, Hansen TN. Antifreeze protein modulates cell survival during cryopreservation: mediation through influence on ice crystal growth. Proc Natl Acad Sci U S A 1992;89:8953-7.
11. Goldman JM, Thng KH, Park DS, et al. Collection, cryopreservation and subsequent viability of haemopoietic stem cells intended for treatment of chronic granulocytic leukemia in blast-cell transformation. Br J Haematol 1987;40:185-95.
12. Donnal TE, Blume KG, Forman SJ. Hematopoietic cell transplantation, 2nd ed. Malden, MA, Blackwell Science, 1998.
13. Nagamura-Inoue T, Shioya M, Sugo M, et al. Wash-out of DMSO does not improve the speed of engraftment of cord blood transplantation: follow-up of 46 adult patients with units shipped from a single cord blood bank. Transfusion 2003;43:1285-94.
14. Feugier P, Bensoussan D, Girard F, et al. Hematologic recovery after autologous PBPC transplantation. importance of the number of postthaw CD34+ cells. Transfusion 2003;43:878-84.
15. David NA. The pharmacology of dimethyl sulfoxide. Annu Rev Pharmacol 1972;12:353-74.
16. Santos NC, Figueira-Coelho J, Martins-Silva J, et al. Multidisciplinary utilization of dimethylsulfoxide: pharmacological, cellular, and molecular aspects. Biochem Pharmacol 2003;65:1035-41.
17. Zambelli A, Poggi G, Da Prada G, et al. Clinical toxicity of cryopreserved circulating progenitor cell infusion. Anticancer Res 1998;18(6B):4705-8.
18. Alessandrino P, Bernasconi P, Caldera D, et al. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant 1999;23:533-7.
19. Keung YK, Lau S, Elkayam U, et al. Cardiac arrhythmia after infusion of cryopreserved stem cells. Bone Marrow Transplant 1994;14:363-7.
20. Hertenstein B, Stefanic M, Schmeiser T, et al. Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant. J Clin Oncol 1994;12:998-1004.
21. Rapoport AP, Rowe JM, Packman CH, et al. Cardiac arrest after autologous marrow infusion. Bone Marrow Transplant 1991;7:401-3.
22. Davis JM, Rowley SD, Braine HG, et al. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990;75:781-6.
23. Okamoto Y, Takaue Y, Saito S, et al. Toxicities associated with cryopreserved and thawed peripheral blood stem cell autografts in children with active cancer. Transfusion 1993;33:578-81.
24. Beaujean F, Hartmann O, Kuentz M, et al. A simple, efficient washing procedure for cryopreserved human hematopoietic stem cells prior to reinfusion. Bone Marrow Transplant 1991;8:291-4.
25. Ayello J, Hesdorffer C, Reiss RF. A semiautomated technique for volume reduction of stem cell suspensions for autotransplantation. J Hematother 1995;4:545-9.
26. Zingsem J, Strasser E, Weisbach V, et al. Cord blood processing with an automated and functionally closed system. Transfusion 2003;43:806-13.
27. Del Mastro L, Venturini M, Viscoli C, et al. Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patients. Ann Oncol 2001;12:505-8.
28. Metcalf D. Technique for the clonal culture of hemopoietic cells: techniques and applications. New York: Elsevier, 1984.
29. Brando B, Barnett D, Janossy G, et al. Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. Cytometry (Comm Clin Cytometry) 2000;42:327-46.
30. Calmels B, Houzé P, Hengesse JC, et al. Preclinical evaluation of an automated closed fluid management device: Cytomate™, for washing out DMSO from hematopoietic stem cell grafts after thawing. Bone Marrow Transplant 2003;31:823-8.
31. Serke S, Arseniev L, Watts M, et al. Imprecision of counting CFU-GM colonies and CD34-expressing cells. Bone Marrow Transplant 1997;20:57-61.